![Global Endoscopic Retrograde Cholangiopancreatography Market](https://res.cloudinary.com/devmoveo/image/upload/v1707486738/skyquest/report/phpDImxOC.jpg)
Report ID: SQMIG35A2748
Report ID:
SQMIG35A2748 |
Region:
Global |
Published Date: July, 2027
Pages:
219
|
Tables:
91 |
Figures:
67
Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 4.41 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).
The advent of minimally invasive surgical techniques has significantly increased the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, paving the way for a thriving industry in the upcoming years. The surge in patients seeking ERCP operations is notably influenced by the advantages of minimally invasive approaches, which offer reduced recovery times and fewer complications compared to traditional surgical methods.
According to the American Cancer Society's annual report released in January 2023, the United States is expected to see an estimated 41,210 new cases of liver cancer, further emphasizing the critical need for advanced diagnostic and therapeutic interventions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2748